Physician profile
Michael L Miles
NPI 1760458319
$1,967.70
in general payments reported to CMS, 2019-2025
31 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $306 · 2021: $478 · 2022: $147 · 2023: $75.75 · 2024: $65.94 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $350.03 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $210.44 | 2019-2025 | Wegovy |
| Astellas Pharma US INC | $203.57 | 2019-2021 | |
| Glaxosmithkline, LLC. | $146.09 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $129.02 | 2019-2021 | |
| Amgen INC. | $116.83 | 2021-2025 | Repatha, Otezla |
| Pfizer INC. | $106.97 | 2019-2025 | |
| Abbott Laboratories | $94.82 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Jazz Pharmaceuticals INC. | $78.27 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $71.68 | 2019-2020 | |
| Exact Sciences Corporation | $53.86 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.13 | 2025 | Caplyta |
| Eisai INC. | $34.63 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $33.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.97 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $25.22 | 2021 | |
| Horizon Therapeutics Plc | $24.82 | 2021 | |
| Harmony Biosciences LLC | $23.87 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.65 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $20.12 | 2022 | |
| Dexcom, INC. | $19.76 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $17.09 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $16.25 | 2025 | Rexulti |
| Acerus Pharmaceuticals Corporation | $15.05 | 2021 | |
| Amarin Pharma, INC. | $14.67 | 2020 | |
| Abbvie INC. | $14.08 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.61 | 2019 | |
| Merck Sharp & Dohme LLC | $12.59 | 2019 | |
| Lilly USA, LLC | $12.59 | 2020 | |
| Shire North American Group INC | $12.05 | 2019 | |
| Echosens North America, INC. | $5.45 | 2024 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.